Colony Bankcorp (NASDAQ:CBAN) reported quarterly earnings of $0.30 per share which missed the analyst consensus estimate of $0.37 by 18.92 percent. This is a 47.37 percent decrease over earnings of $0.57 per share from the same period last year. The company reported quarterly sales of $29.04 million which missed the analyst consensus estimate of $31.69 million by 8.35 percent. This is a 6.36 percent increase over sales of $27.31 million the same period last year.
Jazz Pharmaceuticals Sees FY23 EPS $16.90-$17.85 Vs $18 Est.; FY23 Revenue $3.675B-$3.875B Vs $3.76B Est.
2023 Financial Guidance
Jazz Pharmaceuticals' full year 2023 financial guidance is as follows:
(In
